Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Comparative effectiveness of three Chinese patent medicines for post-stroke convalescence
ChiCTR-OPN-16008374Phase 4Recruiting
- Sponsor
- Tianjin University of Traditional Chinese Medicine
- Start
- Sep 2016
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 4, open-label trial of naoxuekang, xinnaoshutong and xuesetong capsule in stroke (4 arms), sponsored by Tianjin University of Traditional Chinese Medicine. Primary endpoint: National Institutes of Health Stroke Scale. Started Sep 2016; status: recruiting.
02
Drugs
naoxuekangxinnaoshutongxuesetong capsule
03
Conditions
stroke
Beyond the preview
Go deeper on ChiCTR-OPN-16008374.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on ChiCTR-OPN-16008374.